| |||||||
|
|
BIOTECON and MERCK start worldwide marketing alliance PCR-based detection kits for rapid food safety testing Potsdam, Germany, April 15, 2008 / b3c newswire / - In order to enhance the worldwide launch of its innovative food safety testing systems, BIOTECON Diagnostics has formed a strategic marketing alliance with the globally operating MERCK KGaA, Darmstadt, Germany. Merck KGaA sells the foodproof® range which has been available in almost all countries of the world since January 1, 2008. More new products will be launched jointly during the year 2008. Dr. Kornelia Berghof-Jaeger, CEO, BIOTECON Diagnostics: ”In this alliance Merck KGaA will contribute significantly through its expertise in microbiology and its excellent customer relationships. Jointly we are able to fulfill the customer needs by introducing this new technology to the food safety testing labs around the world.” “For Merck KGaA this
partnership means a consequential advancement in order to underline our leading
position in specialty chemicals, especially in analytical reagents and test
kits” comments Wolfgang E. Schmidt, Head of Microbiology, Hygiene and Microscopy
at Merck KGaA. “Our philosophy of highest quality demands is perfectly met by
the solutions offered by BIOTECON Diagnostics.” Under its foodproof® brand BIOTECON Diagnostics has developed real-time PCR detection kits for Enterobacteriaceae plus E. sakazakii (new), Salmonella, Listeria, Campylobacter, E. coli O157 etc. The range also comprises a unique kit for the screening of beer spoilage organisms as well as GMO testing kits. BIOTECON Diagnostics GmbH with its headquarter in Potsdam / Berlin (Germany) has been a competent partner for molecular biological and microbiological issues for more than ten years. The focus is the development, production and marketing of PCR-based rapid detection systems. BIOTECON Diagnostics offers solutions for the food and beverages industry as well as for pharmaceutical and cosmetics manufacturers. Merck KGaA is a global pharmaceutical and chemical company with total revenues of EUR 7.1 billion in 2007, a history that began in 1668, and a future shaped by 30,968 employees in 60 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Link to the news release and to high-resolution pictures: http://www.b3c.de/php/popup.php?id=100 Contact: BIOTECON Diagnostics |
|
| ||||||||